SPOTLIGHT -
The FDA has approved Refocus Group's request to begin phase II clinical trials of its scleral implants and scleral spacing procedure for the surgical treatment of presbyopia.
Seeking a solution to the anesthesia provider shortage
(EyePod) From idea to impact: Navigating ophthalmic innovation
How to boost your efficiency in the OR
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery
The 18th Annual Controversies in Modern Eye Care meeting traces its roots
Insight: A focus on fellows’ training and challenging glaucoma surgical cases